| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Impact Biomedical Inc.'s insiders have reduced their positions by a net 906 shares worth roughly $2K.
IBO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 589.5K | $4.16M | - | |
| Dir | 250.2K | $162.6K | - | |
| CFO | 155.1K | $87.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Heuszel Frank D | Chief Executive Officer | Buy | 500 | $2.26 | $1,128.90 | +0.5% | -48.2% | -79.9% | |
| Nov 27, 2024 | Heuszel Frank D | Chief Executive Officer | Buy | 500 | $2.61 | $1,305.00 | +0.5% | -32.7% | -83.8% | |
| Nov 26, 2024 | Heuszel Frank D | Chief Executive Officer | Buy | 1,050 | $2.61 | $2,738.75 | +1.1% | -22.4% | -84.2% | |
| Nov 18, 2024 | Dss, Inc. | 10% Owner | Sell | 5,700 | $2.99 | $17,023.50 | -9.7% | -33.6% | -85.5% | |
| Sep 18, 2024 | Dss, Inc. | 10% Owner | Buy | 1,000 | $2.33 | $2,330.00 | +1.7% | -5.4% | -72.5% | |
| Sep 17, 2024 | Dss, Inc. | 10% Owner | Buy | 57,800 | $2.65 | $153,220.00 | New | -0.4% | -72.9% |